Close
CDMO Safety Testing 2026
Novotech

RaySearch unveils new version of RayStation treatment planning system

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Colorimeters Enhancing Consistency in Pharma Testing

Maintaining absolute uniformity across multiple production cycles is a fundamental and complex challenge in the pharmaceutical industry. The strategic application of colorimeters pharma testing allows for the precise quantification of hue and saturation, providing a reliable and objective metric for assessing raw material quality and final product stability. These specialized instruments simplify the inherent complexity of color analysis, enabling laboratory technicians to identify subtle variations that might otherwise compromise the efficacy or consumer acceptance of a medicinal product. By establishing a digital standard for appearance, manufacturers ensure that every batch meets the most rigorous quality expectations.

Advanced Color Measurement Strengthening Pharma QC

Achieving absolute precision in pharmaceutical manufacturing necessitates a comprehensive and rigorous oversight of physical attributes, with color serving as a primary indicator of chemical stability and composition. By integrating sophisticated instrumentation into the laboratory environment, manufacturers can transition from subjective visual assessments to standardized, data-driven methodologies that satisfy the most stringent global regulatory requirements. This strategic focus on color measurement pharma QC facilitates the early identification of raw material impurities and ensures uncompromising batch-to-batch consistency in final dosage forms, thereby bolstering patient safety and brand reputation.

GMP Compliance in Analytical Testing and Color Control

Adhering to Good Manufacturing Practices is a non-negotiable requirement for pharmaceutical organizations dedicated to maintaining global safety and quality standards. The intersection of GMP compliance color control and analytical testing ensures that every step of the production process is meticulously documented, validated, and repeatable. By focusing on the rigorous monitoring of physical attributes and chemical purity, manufacturers can mitigate the risks of contamination and stability failures, delivering high-quality healthcare products that patients and healthcare providers can trust implicitly. This disciplined approach ensures that all quality decisions are based on objective, verifiable data.
- Advertisement -

RaySearch Laboratories has launched a new version of its RayStation treatment planning system for clinical use in the European Union, the US, Japan and Australia.

The new RayStation 3.5 version includes a wide range of new features and improvements, including radiation therapy with electrons and protons, along with a Proton Beam Design module.

Proton Beam Design module contains tools for treatment planning of double scattered and uniformly scanned protons, such as a clinically approved Pencil Beam dose engine and automatic generation of treat-and-protect beams.

The proton planning functionality in RayStation, will be followed by many other features, such as Pencil Beam Scanning techniques and Monte Carlo dose calculations.

The new version also comprises Electron Beam Design, which includes a Monte Carlo dose engine for electron radiation therapy and tools for manual editing of beams similar to its earlier 3D-CRT module.

RayStation 3.5 also has new features to the existing IMRT and VMAT modules, which offer the possibility to perform all IMRT and VMAT delivery modes available with all relevant machines from the hardware suppliers.

The new version also offers a broad range of new tools, which includes introduction of Plan Generation Protocols, that help for a better planning workflow and automating tedious treatment planning tasks.

RaySearch CEO Johan Löf said the firms new software version offers support for all treatment modalities and support all IMRT and VMAT delivery modes with all relevant treatment machines.

“RayStation® had already set the standard in terms of usability and with the introduction of Plan Generation Protocols and Fallback Planning we further extend our lead. RayStation® takes a big leap forward to eliminate all unnecessary tedious manual steps and lets the user focus all energy on reviewing, improving and adapting the treatment plans, which are the tasks where the clinical experience matters the most,” Löf added.

 

World Pharma Today brings together the global pharmaceutical industry — from R&D leaders and regulatory affairs professionals to manufacturers and distribution executives — through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium pharmaceutical industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global pharmaceutical and life sciences value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.

Latest stories

Related stories

Colorimeters Enhancing Consistency in Pharma Testing

Maintaining absolute uniformity across multiple production cycles is a fundamental and complex challenge in the pharmaceutical industry. The strategic application of colorimeters pharma testing allows for the precise quantification of hue and saturation, providing a reliable and objective metric for assessing raw material quality and final product stability. These specialized instruments simplify the inherent complexity of color analysis, enabling laboratory technicians to identify subtle variations that might otherwise compromise the efficacy or consumer acceptance of a medicinal product. By establishing a digital standard for appearance, manufacturers ensure that every batch meets the most rigorous quality expectations.

Advanced Color Measurement Strengthening Pharma QC

Achieving absolute precision in pharmaceutical manufacturing necessitates a comprehensive and rigorous oversight of physical attributes, with color serving as a primary indicator of chemical stability and composition. By integrating sophisticated instrumentation into the laboratory environment, manufacturers can transition from subjective visual assessments to standardized, data-driven methodologies that satisfy the most stringent global regulatory requirements. This strategic focus on color measurement pharma QC facilitates the early identification of raw material impurities and ensures uncompromising batch-to-batch consistency in final dosage forms, thereby bolstering patient safety and brand reputation.

GMP Compliance in Analytical Testing and Color Control

Adhering to Good Manufacturing Practices is a non-negotiable requirement for pharmaceutical organizations dedicated to maintaining global safety and quality standards. The intersection of GMP compliance color control and analytical testing ensures that every step of the production process is meticulously documented, validated, and repeatable. By focusing on the rigorous monitoring of physical attributes and chemical purity, manufacturers can mitigate the risks of contamination and stability failures, delivering high-quality healthcare products that patients and healthcare providers can trust implicitly. This disciplined approach ensures that all quality decisions are based on objective, verifiable data.

Choosing Analytical Instruments for Pharma QC Labs

Selecting the right laboratory equipment is a critical decision that directly impacts the efficiency, accuracy, and compliance of pharmaceutical operations. Evaluating analytical instruments pharma QC requirements involves a deep dive into technical specifications, vendor reliability, and the potential for long-term scalability. By choosing tools that integrate seamlessly with existing digital workflows and international regulatory standards, laboratory managers can ensure that their facility is equipped to handle the rigorous demands of modern drug testing and quality assurance. This strategic approach minimizes operational risk and ensures the delivery of safe and effective medications to patients globally.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »